A multivariate study, including 223 BC patients carrying BRCA pathogenic variants and 446 controls with sporadic BC matched for age and year of diagnosis, showed no difference in terms of specific BC survival between BRCA1 or BRCA2 mutation carriers and controls [45]. The gene discussed is BRCA1; the disease is breast cancer.